Skip to main content
SP5007,778.46-0.26%DOW53,717.79-0.23%NASDAQ26,686.20-0.44%BTC$63,019.00-0.19%ETH$1,879.53+0.18%GOLD$4,435.00+0.33%OIL$82.27+1.26%
Smart Investors Daily
Sign InSign Up Free
NO

NASDAQ · NOVT

Novanta Inc.

Technology · Hardware, Equipment & Parts

$167.25

Down-$0.05 (-0.03%)

Updated Aug 14, 2026, 5:54 PM

SID Score

6.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
4.33B
P/E ratio
81.9
Dividend yield
0.00%
52-week range
$111.93 – $176.38
Volume
483.82K
Avg. volume
592.7K

Price performance

NOVT price history

1M range · 21 trading sessions · Daily adjusted prices

NOVT closed at $167.25 after 21 trading sessions, up 11.75% for the selected period.

Last close
$167.25
Period change
+11.75%
Period low
$137.77
Period high
$167.71
Daily close
View OHLC price history
NOVT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 13, 2026$167.04$169.445$166.625$167.25483.82K
Aug 12, 2026$170.00$170.93$165.185$167.04279.45K
Aug 11, 2026$165.74$169.5503$165.08$167.71259.08K
Aug 10, 2026$166.63$169.2409$162.74$163.86349.87K
Aug 7, 2026$166.02$170.39$164.03$166.37448.76K
Aug 6, 2026$169.50$176.375$161.17$163.321.28M
Aug 5, 2026$155.98$160.30$152.44$153.12548.15K
Aug 4, 2026$151.65$159.8599$150.845$159.49634.91K
Aug 3, 2026$144.42$149.27$142.894$148.34382.25K
Jul 31, 2026$141.83$145.39$140.01$142.55363.7K
Jul 30, 2026$140.95$143.23$137.425$138.91480.88K
Jul 29, 2026$139.80$141.57$135.895$137.77489.75K
Jul 28, 2026$139.28$142.61$137.29$141.62498.08K
Jul 27, 2026$143.64$145.245$139.28$140.80290.87K
Jul 24, 2026$143.01$144.52$139.43$141.54357.89K
Jul 23, 2026$142.16$145.895$140.01$143.26287.75K
Jul 22, 2026$144.96$149.65$144.165$145.25401.54K
Jul 21, 2026$145.84$149.15$143.185$145.85352.63K
Jul 20, 2026$148.97$150.335$143.20$143.55408.8K
Jul 17, 2026$144.805$150.00$144.04$148.71343.97K
Jul 16, 2026$143.55$149.99$142.79$149.67497.26K

Latest NOVT news

The latest Smart Investors Daily articles mentioning NOVT.

Stock researchCompany · Overview

NOVT research

Overview

Company profile and research snapshot.

Company profile

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$160.00
Implied upside
—
Analysts
—
NOVT recent ratings
DateFirmRatingTarget
May 13, 2026BairdOutperform—
Mar 30, 2026BairdOutperform—
Aug 11, 2025BairdNeutral—
Mar 3, 2025BairdNeutral—
Nov 6, 2024BairdNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 9, 2026

Novanta (NOVT) Lifted Guidance And Closed Riverpoint, Is The Upside Already Priced In?

What Novanta’s latest guidance and Q2 results mean for the stock Novanta (NOVT) put fresh numbers on the table on 5 August 2026, pairing new third quarter and full year revenue guidance with second quarter results and the recently closed Riverpoint Medical acquisition. The company now guides third quarter 2026 GAAP revenue to US$300 million to US$304 million, with the range reflecting an expected contribution from Riverpoint Medical and an assumption of steady foreign exchange rates. For full...

Yahoo · Aug 9, 2026

Novanta (NOVT) Closes Its Largest Acquisition】【。

Novanta (NasdaqGS:NOVT) has closed its acquisition of RiverPoint Medical, the largest deal in the company's history. The transaction expands Novanta's exposure to medical end markets and is expected to be immediately accretive to revenue growth and margins. Management is accelerating a manufacturing restructuring plan alongside the RiverPoint integration, with potential long-term effects on efficiency and profitability. For investors watching how medical technology companies scale up and...

Yahoo · Aug 7, 2026

Novanta Q2 Earnings Call Highlights

Novanta (NASDAQ:NOVT) reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July closing of its Riverpoint Medical acquisition. Chair and Chief Executive Officer Matthijs Glastra sa

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By